IBRID Trademark

Trademark Overview

On Wednesday, June 3, 2020, a trademark application was filed for IBRID with the United States Patent and Trademark Office. The USPTO has given the IBRID trademark a serial number of 88945371. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, August 23, 2023. This trademark is owned by Glaukos Corporation. The IBRID trademark is filed in the Medical Instrument Products category with the following description:

Ocular implants made of artificial materials and devices, namely, a lumen for allowing for the flow and elution of drugs into the eye for use in treating glaucoma
ibrid

General Information

Serial Number88945371
Word MarkIBRID
Filing DateWednesday, June 3, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, August 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 26, 2021

Trademark Statements

Pseudo MarkI BRID
Goods and ServicesOcular implants made of artificial materials and devices, namely, a lumen for allowing for the flow and elution of drugs into the eye for use in treating glaucoma

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, June 23, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaukos Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92672
Party NameGlaukos Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92672

Trademark Events

Event DateEvent Description
Thursday, August 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 23, 2023SOU EXTENSION 5 GRANTED
Monday, August 21, 2023SOU EXTENSION 5 FILED
Wednesday, August 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 21, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 6, 2023SOU EXTENSION 4 GRANTED
Monday, March 6, 2023SOU EXTENSION 4 FILED
Monday, March 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 12, 2022SOU EXTENSION 3 GRANTED
Friday, August 12, 2022SOU EXTENSION 3 FILED
Friday, August 12, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 23, 2022SOU EXTENSION 2 GRANTED
Wednesday, March 23, 2022SOU EXTENSION 2 FILED
Wednesday, March 23, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 14, 2021SOU EXTENSION 1 GRANTED
Wednesday, July 14, 2021SOU EXTENSION 1 FILED
Wednesday, July 14, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 21, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 21, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 21, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, June 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 27, 2020NON-FINAL ACTION E-MAILED
Saturday, June 27, 2020NON-FINAL ACTION WRITTEN
Saturday, June 27, 2020ASSIGNED TO EXAMINER
Tuesday, June 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 6, 2020NEW APPLICATION ENTERED

Related Keywords

ibrid flow allowing elution drugs glaucoma treating lumen namely made implants